CASTLE BIOSCIENCES INCORPORATED Trademark Portfolio
CASTLE BIOSCIENCES INCORPORATED owns 44 live USPTO trademarks across 4 Nice classes. Earliest filing: 2013-05-06; most recent: 2026-03-20.
Portfolio Overview
| Total Marks | 51 |
|---|---|
| Live Marks | 44 |
| Registered | 17 |
| Pending | 27 |
| Earliest Filing | 2013-05-06 |
| Latest Filing | 2026-03-20 |
Top Classes
Class 044 (Medical Services), Class 010 (Medical Devices), Class 042 (Software & IT), Class 009 (Electronics & Software)
Recently Registered Marks
- I31-ROR — registered 2024-10-01
- I31-SLNB — registered 2024-10-01
- DIFFDX-MELANOMA — registered 2021-12-28
- DIFFDX — registered 2021-12-28
- DECISIONDX-SCC — registered 2021-02-09
Recently Filed Applications
- CELLSCOUT — filed 2026-03-20 (Pending)
- I31-GEP — filed 2026-02-05 (Pending)
- ALIGNAD-DX — filed 2025-09-26 (Pending)
- ADVANCEAD-DX — filed 2025-09-26 (Pending)
- ADVANCEHS-TX — filed 2025-09-26 (Pending)
Top Marks
- I31-SLNB — Registered
- I31-ROR — Registered
- DIFFDX-MELANOMA — Registered
- DIFFDX — Registered
- DECISIONDX-SCC — Registered
- CASTLE BIOSCIENCES — Registered
- DECISIONDX-CMSEQ — Registered
- DECISIONDX-PRAME — Registered
- DECISIONDX-UMSEQ — Registered
- DECISIONDX-MELANOMA — Registered
- DECISIONDX-UM — Registered
- TISSUECYPHER — Registered
- DECISIONDX — Registered
- MAKING PERSONALIZED MEDICINE POSSIBLE — Registered
- IDGENETIX — Registered
- IDGENETIX — Registered
- MYPATH — Registered
- CELLSCOUT — Pending
- I31-GEP — Pending
- ADVANCEAD-DX — Pending
- ALIGNAD-DX — Pending
- ADVANCEHS-TX — Pending
- ADVANCEAD-TX — Pending
- ADVANCETX — Pending
- ALIGNAD-TX — Pending
- ADVANCETX-AD — Pending
- ADVANCEDX-AD — Pending
- ADVANCEIBD-TX — Pending
- ALIGNAD-FLARE — Pending
- ADVANCEFLARE — Pending
- ADVANCEAD-FLARE — Pending
- ADVANCEDX — Pending
- ADVANCETX-IBD — Pending
- ADVANCETX-HS — Pending
- ALIGNAD — Pending
- ADVANCEFLARE-AD — Pending
- PREDICTX-AD — Pending
- INFORMRX-AD — Pending
- DECISIONDX-ECZEMA — Pending
- DECISIONDX-AD — Pending
- INFORM-AD — Pending
- PREDICT-AD — Pending
- DECISIONDX-ATOPICDERMATITIS — Pending
- CASTLE CONNECT — Pending
- I-GEP — Abandoned
- RISK IDENTIFIED — Abandoned
- CONFIRMDX — Abandoned
- CONFIRMDX-MELANOMA — Abandoned
- CONFIRMDX-CM — Abandoned
- DECISIONDX-CSCC — Abandoned